First Time Loading...

Relay Therapeutics Inc
NASDAQ:RLAY

Watchlist Manager
Relay Therapeutics Inc Logo
Relay Therapeutics Inc
NASDAQ:RLAY
Watchlist
Price: 7.06 USD 0.28% Market Closed
Updated: May 7, 2024

Relay Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Relay Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Relay Therapeutics Inc
NASDAQ:RLAY
Cash from Investing Activities
$257.6m
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$4.6B
CAGR 3-Years
-89%
CAGR 5-Years
-21%
CAGR 10-Years
-26%

See Also

What is Relay Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
257.6m USD

Based on the financial report for Dec 31, 2023, Relay Therapeutics Inc's Cash from Investing Activities amounts to 257.6m USD.

What is Relay Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
47%

The average annual Cash from Investing Activities growth rates for Relay Therapeutics Inc have been 47% over the past three years .